These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 34177923)

  • 21. SARS-CoV-2 ORF8 as a Modulator of Cytokine Induction: Evidence and Search for Molecular Mechanisms.
    Móvio MI; Almeida GWC; Martines IDGL; Barros de Lima G; Sasaki SD; Kihara AH; Poole E; Nevels M; Carlan da Silva MC
    Viruses; 2024 Jan; 16(1):. PubMed ID: 38275971
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Elevated temperature inhibits SARS-CoV-2 replication in respiratory epithelium independently of IFN-mediated innate immune defenses.
    Herder V; Dee K; Wojtus JK; Epifano I; Goldfarb D; Rozario C; Gu Q; Da Silva Filipe A; Nomikou K; Nichols J; Jarrett RF; Stevenson A; McFarlane S; Stewart ME; Szemiel AM; Pinto RM; Masdefiol Garriga A; Davis C; Allan J; Graham SV; Murcia PR; Boutell C
    PLoS Biol; 2021 Dec; 19(12):e3001065. PubMed ID: 34932557
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An issue of concern: unique truncated ORF8 protein variants of SARS-CoV-2.
    Hassan SS; Kodakandla V; Redwan EM; Lundstrom K; Pal Choudhury P; Abd El-Aziz TM; Takayama K; Kandimalla R; Lal A; Serrano-Aroca Á; Azad GK; Aljabali AAA; Palù G; Chauhan G; Adadi P; Tambuwala M; Brufsky AM; Baetas-da-Cruz W; Barh D; Azevedo V; Bazan NG; Andrade BS; Santana Silva RJ; Uversky VN
    PeerJ; 2022; 10():e13136. PubMed ID: 35341060
    [TBL] [Abstract][Full Text] [Related]  

  • 24. SARS-CoV-2 protein ORF8 limits expression levels of Spike antigen and facilitates immune evasion of infected host cells.
    Kim IJ; Lee YH; Khalid MM; Chen IP; Zhang Y; Ott M; Verdin E
    J Biol Chem; 2023 Aug; 299(8):104955. PubMed ID: 37354973
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A unique view of SARS-CoV-2 through the lens of ORF8 protein.
    Hassan SS; Aljabali AAA; Panda PK; Ghosh S; Attrish D; Choudhury PP; Seyran M; Pizzol D; Adadi P; Abd El-Aziz TM; Soares A; Kandimalla R; Lundstrom K; Lal A; Azad GK; Uversky VN; Sherchan SP; Baetas-da-Cruz W; Uhal BD; Rezaei N; Chauhan G; Barh D; Redwan EM; Dayhoff GW; Bazan NG; Serrano-Aroca Á; El-Demerdash A; Mishra YK; Palu G; Takayama K; Brufsky AM; Tambuwala MM
    Comput Biol Med; 2021 Jun; 133():104380. PubMed ID: 33872970
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differential immune activation profile of SARS-CoV-2 and SARS-CoV infection in human lung and intestinal cells: Implications for treatment with IFN-β and IFN inducer.
    Shuai H; Chu H; Hou Y; Yang D; Wang Y; Hu B; Huang X; Zhang X; Chai Y; Cai JP; Chan JF; Yuen KY
    J Infect; 2020 Oct; 81(4):e1-e10. PubMed ID: 32707230
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antiviral Activity of Type I, II, and III Interferons Counterbalances ACE2 Inducibility and Restricts SARS-CoV-2.
    Busnadiego I; Fernbach S; Pohl MO; Karakus U; Huber M; Trkola A; Stertz S; Hale BG
    mBio; 2020 Sep; 11(5):. PubMed ID: 32913009
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impaired local intrinsic immunity to SARS-CoV-2 infection in severe COVID-19.
    Ziegler CGK; Miao VN; Owings AH; Navia AW; Tang Y; Bromley JD; Lotfy P; Sloan M; Laird H; Williams HB; George M; Drake RS; Christian T; Parker A; Sindel CB; Burger MW; Pride Y; Hasan M; Abraham GE; Senitko M; Robinson TO; Shalek AK; Glover SC; Horwitz BH; Ordovas-Montanes J
    Cell; 2021 Sep; 184(18):4713-4733.e22. PubMed ID: 34352228
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Glycosylated, Lipid-Binding, CDR-Like Domains of SARS-CoV-2 ORF8 Indicate Unique Sites of Immune Regulation.
    Wu F; Chen X; Ma Y; Wu Y; Li R; Huang Y; Zhang R; Zhou Y; Zhan J; Liu S; Xu W
    Microbiol Spectr; 2023 Aug; 11(4):e0123423. PubMed ID: 37318366
    [TBL] [Abstract][Full Text] [Related]  

  • 30. SARS-CoV-2 Isolates Show Impaired Replication in Human Immune Cells but Differential Ability to Replicate and Induce Innate Immunity in Lung Epithelial Cells.
    Jiang M; Kolehmainen P; Kakkola L; Maljanen S; Melén K; Smura T; Julkunen I; Österlund P
    Microbiol Spectr; 2021 Sep; 9(1):e0077421. PubMed ID: 34378952
    [TBL] [Abstract][Full Text] [Related]  

  • 31. IFN-γ-mediated control of SARS-CoV-2 infection through nitric oxide.
    Silva BJA; Krogstad PA; Teles RMB; Andrade PR; Rajfer J; Ferrini MG; Yang OO; Bloom BR; Modlin RL
    Front Immunol; 2023; 14():1284148. PubMed ID: 38162653
    [TBL] [Abstract][Full Text] [Related]  

  • 32. SARS-CoV-2 ORF8 reshapes the ER through forming mixed disulfides with ER oxidoreductases.
    Liu P; Wang X; Sun Y; Zhao H; Cheng F; Wang J; Yang F; Hu J; Zhang H; Wang CC; Wang L
    Redox Biol; 2022 Aug; 54():102388. PubMed ID: 35792438
    [TBL] [Abstract][Full Text] [Related]  

  • 33. SARS-CoV-2 infection activates a subset of intrinsic pathways to inhibit type I interferons
    Luo W; Huang L; Wang X; Ma Y; Xiao J; Song X; Liu P; Wang Y; Wang Y; Ren Z
    Int J Med Sci; 2021; 18(12):2561-2569. PubMed ID: 34104087
    [TBL] [Abstract][Full Text] [Related]  

  • 34. SARS-CoV-2 ORF8 Protein Induces Endoplasmic Reticulum Stress-like Responses and Facilitates Virus Replication by Triggering Calnexin: an Unbiased Study.
    Wang X; Wang W; Wang T; Wang J; Jiang Y; Wang X; Qiu Z; Feng N; Sun W; Li C; Yang S; Xia X; He H; Gao Y
    J Virol; 2023 Mar; 97(3):e0001123. PubMed ID: 36877072
    [TBL] [Abstract][Full Text] [Related]  

  • 35. SARS-CoV-2 disrupts host epigenetic regulation via histone mimicry.
    Kee J; Thudium S; Renner DM; Glastad K; Palozola K; Zhang Z; Li Y; Lan Y; Cesare J; Poleshko A; Kiseleva AA; Truitt R; Cardenas-Diaz FL; Zhang X; Xie X; Kotton DN; Alysandratos KD; Epstein JA; Shi PY; Yang W; Morrisey E; Garcia BA; Berger SL; Weiss SR; Korb E
    Nature; 2022 Oct; 610(7931):381-388. PubMed ID: 36198800
    [TBL] [Abstract][Full Text] [Related]  

  • 36. SARS-CoV-2 ORF8 is a viral cytokine regulating immune responses.
    Kohyama M; Suzuki T; Nakai W; Ono C; Matsuoka S; Iwatani K; Liu Y; Sakai Y; Nakagawa A; Tomii K; Ohmura K; Okada M; Matsuura Y; Ohshima S; Maeda Y; Okamoto T; Arase H
    Int Immunol; 2023 Jan; 35(1):43-52. PubMed ID: 36053553
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Similarities and differences in the conformational stability and reversibility of ORF8, an accessory protein of SARS-CoV-2, and its L84S variant.
    Ohki S; Imamura T; Higashimura Y; Matsumoto K; Mori M
    Biochem Biophys Res Commun; 2021 Jul; 563():92-97. PubMed ID: 34062392
    [TBL] [Abstract][Full Text] [Related]  

  • 38. SARS-CoV-2 ORF8: A Rapidly Evolving Immune and Viral Modulator in COVID-19.
    Arduini A; Laprise F; Liang C
    Viruses; 2023 Mar; 15(4):. PubMed ID: 37112851
    [TBL] [Abstract][Full Text] [Related]  

  • 39. SARS-CoV-2 Accessory Protein ORF8 Decreases Antibody-Dependent Cellular Cytotoxicity.
    Beaudoin-Bussières G; Arduini A; Bourassa C; Medjahed H; Gendron-Lepage G; Richard J; Pan Q; Wang Z; Liang C; Finzi A
    Viruses; 2022 Jun; 14(6):. PubMed ID: 35746708
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evolutionary dynamics of the SARS-CoV-2 ORF8 accessory gene.
    Pereira F
    Infect Genet Evol; 2020 Nov; 85():104525. PubMed ID: 32890763
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.